Haemophilus influenzae type b vaccine formulation and risk of childhood leukaemia

Incidence of childhood leukaemia was studied among subjects of a vaccine trial in Finland comparing the polysaccharide–diptheria toxoid conjugate and oligosaccharide–CRM197 conjugate Haemophilus influenzae type b conjugate vaccine formulations. Eighty cases of childhood leukaemia were detected: 35 a...

Descripción completa

Detalles Bibliográficos
Autores principales: Groves, F, Sinha, D, Auvinen, A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2002
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376162/
https://www.ncbi.nlm.nih.gov/pubmed/12189546
http://dx.doi.org/10.1038/sj.bjc.6600489
Descripción
Sumario:Incidence of childhood leukaemia was studied among subjects of a vaccine trial in Finland comparing the polysaccharide–diptheria toxoid conjugate and oligosaccharide–CRM197 conjugate Haemophilus influenzae type b conjugate vaccine formulations. Eighty cases of childhood leukaemia were detected: 35 among children on the polysaccharide–diptheria toxoid conjugate arm, and 45 among children on the oligosaccharide–CRM197 conjugate arm, which was not statistically significant. British Journal of Cancer (2002) 87, 511–512. doi:10.1038/sj.bjc.6600489 www.bjcancer.com © 2002 Cancer Research UK

Ejemplares similares